 Genetic Vectors
"Genetic Vectors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition.
| Descriptor ID |
D005822
|
| MeSH Number(s) |
G05.360.337
|
| Concept/Terms |
Genetic Vectors- Genetic Vectors
- Genetic Vector
- Vector, Genetic
- Vectors, Genetic
Shuttle Vectors- Shuttle Vectors
- Shuttle Vector
- Vector, Shuttle
- Vectors, Shuttle
Cloning Vectors- Cloning Vectors
- Cloning Vector
- Vector, Cloning
- Vectors, Cloning
|
Below are MeSH descriptors whose meaning is more general than "Genetic Vectors".
Below are MeSH descriptors whose meaning is more specific than "Genetic Vectors".
This graph shows the total number of publications written about "Genetic Vectors" by people in this website by year, and whether "Genetic Vectors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 3 | 7 | | 1997 | 1 | 3 | 4 | | 1998 | 3 | 7 | 10 | | 1999 | 1 | 2 | 3 | | 2000 | 2 | 9 | 11 | | 2001 | 6 | 12 | 18 | | 2002 | 7 | 6 | 13 | | 2003 | 7 | 9 | 16 | | 2004 | 7 | 9 | 16 | | 2005 | 2 | 13 | 15 | | 2006 | 2 | 7 | 9 | | 2007 | 1 | 11 | 12 | | 2008 | 5 | 12 | 17 | | 2009 | 5 | 4 | 9 | | 2010 | 0 | 5 | 5 | | 2011 | 3 | 6 | 9 | | 2012 | 6 | 4 | 10 | | 2013 | 1 | 7 | 8 | | 2014 | 4 | 3 | 7 | | 2015 | 1 | 5 | 6 | | 2016 | 1 | 2 | 3 | | 2017 | 3 | 6 | 9 | | 2018 | 0 | 7 | 7 | | 2019 | 5 | 2 | 7 | | 2020 | 3 | 7 | 10 | | 2021 | 3 | 3 | 6 | | 2022 | 1 | 2 | 3 | | 2023 | 0 | 4 | 4 | | 2024 | 1 | 4 | 5 | | 2025 | 2 | 1 | 3 | | 2026 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Genetic Vectors" by people in Profiles.
-
Calton MA, Croze RH, Sullivan TH, Collins SA, Tucker S, Whittlesey KJ, Kim DH, Nye JA, Beliakoff G, Quezada M, Burns C, Schmitt C, Klein A, Jia V, Kovacs L, Lauko D, Yoh K, Nguyen K, Barglow K, Gonzales J, Khoday D, Mason T, Delaria K, Bashour K, Kotterman M, Schaffer D, Song A, Francis P, Taylor-Cousar JL, Kirn D. Design and characterization of 4D-710, an aerosolized gene therapy for cystic fibrosis lung disease. Am J Respir Cell Mol Biol. 2026 Jul 01; 74(7):837-846.
-
Mundy RM, Waraich K, Bates EA, Rizkallah PJ, Baker AT, Young MT, Morris E, da Fonseca PCA, Bliss CM, Matthews D, Bhella D, Parker AL. Identification of a novel fiber shaft structural motif and overexpression of key transcripts elucidated in human adenovirus D 10. PLoS Pathog. 2026 Apr; 22(4):e1014182.
-
Wang S, Zhang P, Sun Y, Fang Y, Wang P, Shao M, Zhang N, Shi S, Chen X, Gao H, Cheng J, Gao B, Liu T, Qian Q, Song C. Engineering of BZ transposase and transposon donor vector for enhanced efficiency and safety in gene delivery applications. Nucleic Acids Res. 2025 Sep 23; 53(18).
-
Patrick C, Petroff M, Plegaria J, Razinkov V, Padmakumar S, Mallela KMG. Polysorbates and poloxamer rescue filter-induced serotype-dependent loss of AAVs. J Pharm Sci. 2025 07; 114(7):103825.
-
Cao M, Katial R, Liu Y, Lu X, Gu Q, Chen C, Liu K, Zhu Z, Marshall MR, Yu Y, Wang Z. Safety, efficacy, and immunogenicity of a novel IgG degrading enzyme (KJ103): results from two randomised, blinded, phase 1 clinical trials. Gene Ther. 2025 05; 32(3):223-236.
-
Voit RA, Liao X, Caulier A, Antoszewski M, Cohen B, Armant M, Lu HY, Fleming TJ, Kamal E, Wahlster L, Roche AM, Everett JK, Petrichenko A, Huang MM, Clarke W, Myers KC, Forester C, Perez-Atayde A, Bushman FD, Pellin D, Shimamura A, Williams DA, Sankaran VG. Regulated GATA1 expression as a universal gene therapy for Diamond-Blackfan anemia. Cell Stem Cell. 2025 Jan 02; 32(1):38-52.e6.
-
Naing A, Khalil D, Rosen O, Camidge DR, Lillie T, Ji RR, Stacey A, Thomas M, Rosen L. First-in-human clinical outcomes with NG-350A, an anti-CD40 expressing tumor-selective vector designed to remodel immunosuppressive tumor microenvironments. J Immunother Cancer. 2024 Oct 15; 12(10).
-
O'Donnell M, Fontaine A, Caldwell J, Weir R. Direct dorsal root ganglia (DRG) injection in mice for analysis of adeno-associated viral (AAV) gene transfer to peripheral somatosensory neurons. J Neurosci Methods. 2024 11; 411:110268.
-
Hughes AC, Pittman BG, Xu B, Gammons JW, Webb CM, Nolen HG, Chapman P, Bikoff JB, Schwarz LA. A single-vector intersectional AAV strategy for interrogating cellular diversity and brain function. Nat Neurosci. 2024 Jul; 27(7):1400-1410.
-
Ball JB, Frank MG, Green-Fulgham SM, Watkins LR. Use of adeno-associated viruses for transgenic modulation of microglia structure and function: A review of technical considerations and challenges. Brain Behav Immun. 2024 May; 118:368-379.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|